Back
Inhibrx Biosciences, Inc. Vs. Keros Therapeutics, Inc. Industry Stock Comparison
Sell
42
INBX
Inhibrx Biosciences, Inc.
Last Price:
$79.24
Seasonality Move:
-1.59%
Buy
54
KROS
Keros Therapeutics, Inc.
Last Price:
$20.65
Seasonality Move:
4.91%
Sell
42
Inhibrx Biosciences, Inc. (INBX)
is a Sell
Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?
-
The current Inhibrx Biosciences, Inc. [INBX] share price is $79.27. The Score for INBX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Keros Therapeutics, Inc. [KROS] share price is $20.63. The Score for KROS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INBX Stock Price Chart
What is Inhibrx Biosciences, Inc.'s stock price today?
-
The Inhibrx Biosciences, Inc. share price today is $79.27The current trend is moderately bearish and INBX is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics, Inc.'s stock price today?
-
The Keros Therapeutics, Inc. share price today is $20.63The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 48.38 | Sell |
| Chaikin Money Flow: | -72274 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.56 - 87.22) | Sell |
| Bollinger Bands (100): | (26.15 - 78.23) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 57.05 | Buy |
| Chaikin Money Flow: | -192087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.1 - 21.78) | Buy |
| Bollinger Bands (100): | (14.31 - 18.87) | Buy |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.5 | Sell |
| 20-day SMA: | 83.47 | Sell |
| 50-day SMA: | 75.75 | Buy |
| 200-day SMA: | 33.75 | Buy |
| 8-day EMA: | 81.4 | Sell |
| 20-day EMA: | 81.7 | Sell |
| 50-day EMA: | 73.17 | Buy |
| 200-day EMA: | 43.05 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.87 | Sell |
| 20-day SMA: | 20.58 | Buy |
| 50-day SMA: | 17.94 | Buy |
| 200-day SMA: | 15 | Buy |
| 8-day EMA: | 20.95 | Sell |
| 20-day EMA: | 20.33 | Buy |
| 50-day EMA: | 18.66 | Buy |
| 200-day EMA: | 18.79 | Buy |
Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, a decrease this year of $120.61 per share, and an increase next year of $4.25 per share.
Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.
Inhibrx Biosciences, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||